Biotech · Private company
PathMaker Neurosystems Inc.
Track this companyFree. Adds PathMaker Neurosystems Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Multi-site direct current stimulation (DCS)ALS - Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- MyoRegulator®Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- MyoRegulator® deviceMuscle SpasticityClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability StudyNA · RECRUITING · started Feb 10, 2025ClinicalTrials.gov NCT06649955 · fetched Nov 12, 2026
- Early Feasibility Study of the MyoRegulator® for Treatment of ALSNA · COMPLETED · started Jun 21, 2023ClinicalTrials.gov NCT06165172 · fetched Nov 12, 2026
- Dual Stimulation for Spinal Cord InjuryNA · COMPLETED · started Jul 14, 2022ClinicalTrials.gov NCT07467850 · fetched Nov 12, 2026
- Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb SpasticityNA · TERMINATED · started Mar 4, 2022ClinicalTrials.gov NCT04742257 · fetched Nov 12, 2026